Atlas Trials

Multiple Sclerosis

2,624 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Multiple Sclerosis

RecordFirmDate
Computerized Cognitive Rehabilitation in MS Patients (NCT03729713)Rutgers, The State University of New Jersey2021-04-21
Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA) (NCT04843774)NYU Langone Health2021-04-20
The Effects of Respiratory-based Telerehabilitaion in Patients With MS (NCT04887051)Dr. Anıl Tosun2021-04-16
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People (NCT04844489)Assistance Publique - Hôpitaux de Paris2021-04-16
The Effect of Telerehabilitation Based Pilates Training in Multiple Sclerosis Patients (NCT04838886)Gazi University2021-04-15
Lifestyle Intervention for Patients With Multiple Sclerosis (NCT05402501)Amsterdam UMC, location VUmc2021-04-15
An International, Multicenter, Randomized, Double-Blind, Double-Masked Study of the Efficacy and Safety of BCD-132 (JSC BIOCAD, Russia) Using an Active Reference Drug (Teriflunomide) for the Treatment of Patients With Multiple Sclerosis (NCT05385744)Biocad2021-04-05
Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients (NCT04625049)Turku University Hospital2021-04-01
Development and Application of Tele-Neuro Rehabilitation System (NCT05031403)Istanbul University - Cerrahpasa2021-04-01
Virtual Reality in Physical Therapy in Multiple Sclerosis (NCT04807738)Charles University, Czech Republic2021-04-01
COVID-19 and Multiple Sclerosis Disease Modifying Therapies (NCT04863586)Nottingham University Hospitals NHS Trust2021-04-01
Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple Sclerosis (NCT04930380)University of Siena2021-04-01
The Effect of Cervical Mobilization on Balance and Spasticity in Multiple Sclerosis Individuals (NCT03706131)Hacettepe University2021-04-01
An Assistive Powered Wheelchair: Stage 2 Trial (NCT05292690)East Kent Hospitals University NHS Foundation Trust2021-03-29
Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMS (NCT04963335)Eling DeBruin2021-03-28
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults (NCT04952766)Centre Hospitalier Régional d'Orléans2021-03-26
Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients- (NCT04843813)University of Illinois at Urbana-Champaign2021-03-26
Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects (NCT04699747)Massachusetts General Hospital2021-03-25
The MS-LINK™ Outcomes Study (NCT04735406)EMD Serono Research & Development Institute, Inc.2021-03-24
IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis (NCT04697407)Rennes University Hospital2021-03-23
Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis (NCT04834401)St. Barnabas Medical Center2021-03-22
Understanding and Enhancing Human Health and Movement (NCT07738978)Louis Stokes VA Medical Center2021-03-21
Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab (NCT05075499)Sheba Medical Center2021-03-20
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their Infants (NCT06133049)Bristol-Myers Squibb2021-03-16
Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera (NCT04756687)Biogen2021-03-10
Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension) (NCT04783935)Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2021-03-10
Offering Support and Electronic Resources for Care Partners of Those With Multiple Sclerosis (NCT04662008)Case Western Reserve University2021-03-10
Digital Gait Analysis in the Home Environment of Patients With Multiple Sclerosis (NCT04771858)Medical Valley Digital Health Application Center GmbH2021-03-09
Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment. (NCT04882891)Centre Hospitalier Universitaire de Liege2021-03-09
Tele-Assessment and Face-to-Face Evaluation of Balance in MS (NCT04743284)Istanbul University - Cerrahpasa2021-03-05
Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis (NCT05748015)Istituti Clinici Scientifici Maugeri SpA2021-03-04
The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple Sclerosis (NCT05017038)Central Hospital, Nancy, France2021-03-03
Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab (NCT04837651)Dragonfly Research, LLC2021-03-02
Hypnosis and Direct Autonomic Experience Influence on Chronic Symptoms (NCT04303143)Inner Group Inc.2021-03-01
LUNA-EMG to Enhance Motor Functions in Multiple Sclerosis (NCT04720898)University of Liege2021-03-01
Home Based Infusions for Ocrelizumab (NCT04650321)University of Colorado, Denver2021-03-01
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment (NCT06281314)IRCCS Centro Neurolesi Bonino Pulejo2021-03-01
Determination of Compliance to Mediterranean Diet, Impacts on Walking and Quality of Life in Multiple Sclerosis (NCT05777629)University of Gaziantep2021-02-28
Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers (NCT04725175)Contineum Therapeutics2021-02-26
Validation of the BeCare Multiple Sclerosis Assessment App (NCT04288011)BeCare Link LLC2021-02-26
Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis. (NCT05811949)IRCCS Centro Neurolesi Bonino Pulejo2021-02-24
Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension) (NCT04776213)Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2021-02-23
Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis (NCT04054050)Johns Hopkins University2021-02-22
Impact of Core Performance on Functional Parameters in Multiple Sclerosis (NCT04750733)Istanbul University - Cerrahpasa2021-02-20
Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis (NCT04633759)University of Colorado, Denver2021-02-19
Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple Sclerosis (NCT04891341)Hacettepe University2021-02-16
Trabecular Bone Score in Multiple Sclerosis (NCT05811689)IRCCS Centro Neurolesi Bonino Pulejo2021-02-14
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients (NCT05286242)Yale University2021-02-10
Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment. (NCT04888689)Laurent Servais2021-02-04
The Minnesota Manual Dexterity Test As A Measure Of Hand Function in Multiple Sclerosis (NCT04721340)Istanbul Aydın University2021-02-02
Validity and Reliability of the Dual-task Questionnaire (NCT05188937)Gazi University2021-02-01
A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort. (NCT04760990)University Hospital, Basel, Switzerland2021-02-01
A ToM Training for People With Multiple Sclerosis: an Efficacy Study. (NCT04711941)Fondazione Don Carlo Gnocchi ETS2021-02-01
Effect of Variance on Error Correction During Coupling (NCT04856384)Hasselt University2021-02-01
Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis (NCT02912897)Nantes University Hospital2021-01-26
Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis (NCT04932616)Istanbul University - Cerrahpasa2021-01-26
Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients (NCT02747914)University of Belgrade2021-01-25
Home Based Tele-exercise for People With Chronic Neurological Impairments (NCT04564495)Burke Medical Research Institute2021-01-22
Sonification Techniques for Gait Training (NCT04876339)Istituti Clinici Scientifici Maugeri SpA2021-01-18
The Energetic Origin of Neurodegeneration in MS (NCT04532944)Institut National de la Santé Et de la Recherche Médicale, France2021-01-13
Barriers to Physical Activity in People With MS (NCT04746807)University of Zurich2021-01-08
Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients (NCT04682548)NYU Langone Health2021-01-05
Effects of A Dual-Task Intervention in Postural Control in Multiple Sclerosis Patients (NCT04090996)University Hospital, Limoges2021-01-04
Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation (NCT04674280)European Society for Blood and Marrow Transplantation2021-01-01
Deficit-specific Training in Spinal Disorders (NCT04292717)University of Zurich2021-01-01
Evaluation of the Presence and Effects of Kinesiophobia in Multiple Sclerosis (NCT06167447)Gazi University2021-01-01
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis (NCT02200718)Immune Response BioPharma, Inc.2020-12-31
Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation (NCT04230174)Massachusetts General Hospital2020-12-29
Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS Patients (NCT05002062)Cairo University2020-12-21
Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple Sclerosis (NCT05078177)St. Petersburg State Pavlov Medical University2020-12-21
Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping) (NCT04465448)Fondation Ophtalmologique Adolphe de Rothschild2020-12-17
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy (NCT04640818)Claudio Gobbi2020-12-17
Cognitive Improvement Through tDCS for Patients With Multiple Sclerosis (NCT04667221)University Medicine Greifswald2020-12-08
Power Training in Older Multiple Sclerosis Patients (NCT04762342)University of Aarhus2020-12-07
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) (NCT04548999)Hoffmann-La Roche2020-12-03
Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis. (NCT05576779)Novartis Pharmaceuticals2020-12-03
iTBS Study for Depression in Patients With Multiple Sclerosis (NCT04524039)Third Affiliated Hospital, Sun Yat-Sen University2020-12-01
Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study (NCT05175378)Iaso Maternity Hospital, Athens, Greece2020-12-01
MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis (NCT04806568)Aristotle University Of Thessaloniki2020-12-01
National, Multicentric Registry Study on Neuroimmunological Diseases in China (NCT06443333)Xuanwu Hospital, Beijing2020-12-01
Upper Limb Telerehabilitation With Virtual Reality in Multiple Sclerosis (NCT04032431)University of Cagliari2020-12-01
Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple Sclerosis (NCT04707976)Wellspect HealthCare2020-12-01
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) (NCT04544436)Hoffmann-La Roche2020-11-26
Famciclovir in Multiple Sclerosis (NCT05283551)Queen Mary University of London2020-11-25
US PROmyBETAapp2.0: A Study to Learn More About the Medication Usage and Patient Reported Outcomes Via the myBETAapp in Medical Care of Patients With Multiple Sclerosis Treated With BETASERON Using BETACONNECT Autoinjector (NCT04356339)Bayer2020-11-24
Investigation of Subclinical Markers of Multiple Sclerosis (NCT04604041)University of Split, School of Medicine2020-11-23
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies (NCT06459232)Novartis2020-11-19
Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMS (NCT04838015)University Hospital, Strasbourg, France2020-11-13
Cognitive-motor Dual Task Training in Patients With Multiple Sclerosis (NCT04619953)I.R.C.C.S. Fondazione Santa Lucia2020-11-09
Auditory-motor Coupling in Multiple Sclerosis With Cerebellar Lesions (NCT04639401)Hasselt University2020-11-09
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis (NCT04496804)University of Alabama at Birmingham2020-11-02
Epley Manoeuvre in Participants With Multiple Sclerosis Diagnosed From Benign Paroxysmal Positional Vertigo (NCT04578262)University of Seville2020-11-01
TELEMS: Feasibility of Remote Patient Visits in MS (NCT04838990)Medical University of Vienna2020-11-01
Effectiveness of Hippotherapy Simulator in PwMS (NCT04651725)Uşak University2020-11-01
Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis (NCT04855617)NYU Langone Health2020-10-26
Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour (NCT04832269)Jena University Hospital2020-10-19
My MS Toolkit + Coaching: A Guided Web-based Symptom Self-Management Program for People With MS (NCT04552561)University of Michigan2020-10-19
Non-invasive Transcranial Electrical Stimulation in MS (NCT04466228)University of California, San Francisco2020-10-16
Assessing the Feasibility of the MSPT Device in Routine Clinical Practice in the Swiss Healthcare System (NCT04599023)Insel Gruppe AG, University Hospital Bern2020-10-16
Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS) (NCT05003375)KU Leuven2020-10-15
← Previous Next →

Track Multiple Sclerosis automatically

Every clearance here is in the API, with alerts when new ones post.